Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

LignaMed

LignaMed
2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
3 INVESTORS
Description

Developer of molecule therapy for the treatment for cancer. The company develops therapeutics from flaxseed derivatives to amplify effects of chemotherapy and radiation treatment on cancer cells.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Primary Office
  • Philadelphia, PA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore LignaMed’s full profile, request a free trial.

LignaMed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 10-Mar-2015 Completed Startup
2. Accelerator/Incubator 04-Mar-2015 Completed Startup
1. Grant 18-Jan-2014 $825K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

LignaMed Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UPstart Accelerator/Incubator 000 0000 000000 0
Science Center Accelerator/Incubator 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0

LignaMed Executive Team (3)

Name Title Board
Seat
Contact
Info
Thais Sielecki Chief Scientific Officer
Melpo Christofidou Solomidou Ph.D Founder & Chair of Scientific Advisory Board
Jim Harris Chief Executive Officer

LignaMed Board Members (2)

Name Representing Role Since Contact
Info
Dora Mitchell Ph.D UPstart Board Member 000 0000
Melpo Christofidou Solomidou Ph.D LignaMed Founder & Chair of Scientific Advisory Board 000 0000